Priorities for UK trade liberalisation
As the UK develops its trade policy outside of the EU, it would be a mistake to base its future approach on the one it inherits from the EU.
Eliminemos aranceles para derrotar al coronavirus
La demanda sin precedentes por parte de hospitales que están almacenando medicamentos básicos ha causado escasez y aumento de precios a nivel mundial.
Tariffs are hurting patients – and hampering the fight against Covid
While researchers in universities and private-sector laboratories work round-the-clock for new treatments and vaccines for Covid-19, physicians rely on a broad cabinet of older medicines to help patients through their darkest hour.
Abolishing pharmaceutical and vaccine tariffs to promote access
The Covid-19 pandemic has illustrated the importance of global trade for access to all kinds of medical supplies, with many jurisdictions suffering shortages of essential medical goods as a result of various trade barriers.
Trade Barriers Stand in the Way of Defeating COVID-19
At the 73rd World Health Assembly earlier this week, public health officials from dozens of countries gathered — virtually, of course — to discuss strategies to defeat COVID-19.
A Joint Declaration on the Importance of Collaboration, Open Trade, and Innovation in Tackling COVID-19
We are an international coalition of public policy research institutes and think tanks that believes that the collaboration, open trade and innovation will provide the solutions to the COVID-19 crisis.
CodeBlue Reports on Improving Access to Medicines
CodeBlue wrote an article, “Low Cost Measures To Tackle Health SDGs Proposed Ahead of UN Meeting” highlighting the major recommendations of the Improving Access to Medicines report that a coalition of think tanks, including Geneva Network, published ahead of the 74th session of the United
Improving access to medicines to meet the SDGs
Improving access to medicines and quality healthcare remains a key area of action for the member states of the United Nations.
Will the USMCA IP chapter increase spending on medicines?
As parties to the United States-Mexico-Canada Agreement (USMCA), Canada and Mexico have agreed to adopt important intellectual property protections for biologic medicines.